Thomas Klingebiel

1991–2025 年に発表

134
論文数
19,762
被引用数
83
h 指数
130
i10 指数

被引用数

Thomas Klingebiel の年別被引用数1943 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 6 件1998 年: 被引用 9 件1999 年: 被引用 7 件2000 年: 被引用 5 件2001 年: 被引用 23 件2002 年: 被引用 26 件2003 年: 被引用 55 件2004 年: 被引用 51 件2005 年: 被引用 65 件2006 年: 被引用 73 件2007 年: 被引用 80 件2008 年: 被引用 104 件2009 年: 被引用 123 件2010 年: 被引用 132 件2011 年: 被引用 148 件2012 年: 被引用 167 件2013 年: 被引用 140 件2014 年: 被引用 137 件2015 年: 被引用 165 件2016 年: 被引用 106 件2017 年: 被引用 149 件2018 年: 被引用 92 件2019 年: 被引用 629 件2020 年: 被引用 583 件2021 年: 被引用 672 件2022 年: 被引用 489 件2023 年: 被引用 331 件2024 年: 被引用 506 件2025 年: 被引用 230 件2026 年: 被引用 1 件1944〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,879 件、この内訳の 20.7%ドイツ: 引用元論文 1,024 件、この内訳の 11.3%イギリス: 引用元論文 562 件、この内訳の 6.2%イタリア: 引用元論文 535 件、この内訳の 5.9%フランス: 引用元論文 461 件、この内訳の 5.1%オランダ: 引用元論文 448 件、この内訳の 4.9%中国: 引用元論文 368 件、この内訳の 4.1%カナダ: 引用元論文 303 件、この内訳の 3.3%スイス: 引用元論文 288 件、この内訳の 3.2%スペイン: 引用元論文 268 件、この内訳の 3%オーストリア: 引用元論文 257 件、この内訳の 2.8%オーストラリア: 引用元論文 221 件、この内訳の 2.4%
0%20.7%その他 27.1%

分野

  • Medicine73.2%
  • Biochemistry, Genetics and Molecular Biology15.9%
  • Immunology and Microbiology8.1%
  • Psychology0.6%
  • Computer Science0.4%
  • Engineering0.4%
  • その他1.4%

トピック

  • Acute Lymphoblastic Leukemia research7.6%
  • CAR-T cell therapy research5.3%
  • Acute Myeloid Leukemia Research4.4%
  • Sarcoma Diagnosis and Treatment4.3%
  • Neuroblastoma Research and Treatments4.1%
  • Hematopoietic Stem Cell Transplantation4.1%
  • その他70.2%

共著者

全論文

検索で開く
  1. The landscape of genomic alterations across childhood cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jenny Wegert, Roland Kappler, Daniel Baumhoer, Stefan Burdach, Renate Kirschner‐Schwabe, Udo Kontny, Andreas E. Kulozik, Dietmar Lohmann, Simone Hettmer, Cornelia Eckert, Stefan Bielack, Michaela Nathrath, Charlotte M. Niemeyer, Günther Richter, Johannes H. Schulte, Reiner Siebert, Frank Westermann, Jan J. Molenaar, Gilles Vassal, Hendrik Witt, Birgit Burkhardt, Christian P. Kratz, Olaf Witt, Cornelis M. van Tilburg, Christof M. Kramm, Gudrun Fleischhack, Uta Dirksen, Stefan Rutkowski, Michael C. Frühwald, Katja von Hoff, Stephan Wolf, Thomas Klingebiel, Ewa Kościelniak, Pablo Landgraf, Jan Köster, Adam Resnick, Jinghui Zhang, Yanling Liu, Xin Zhou, Angela J. Waanders, Danny A. Zwijnenburg, Pichai Raman, Benedikt Brors, Ursula Weber, Paul A. Northcott, Kristian W. Pajtler, Marcel Kool, Rosario M. Piro, Jan O. Korbel, Matthias Schlesner, Roland Eils, David Jones, Peter Lichter, Lukas Chávez, Marc Zapatka, Stefan M. Pfister - Nature 2018 被引用: 1,634

  2. Sarcoma classification by DNA methylation profiling

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schick, Melanie Bewerunge‐Hudler, Till Milde, Olaf Witt, Andreas E. Kulozik, Marcel Kool, Laura Romero‐Pérez, Thomas G. P. Grünewald, Thomas Kirchner, Wolfgang Wick, Michael Platten, Andreas Unterberg, Matthias Uhl, Amir Abdollahi, Jürgen Debus, Burkhard Lehner, Christian Thomas, Martin Hasselblatt, Werner Paulus, Christian Hartmann, Ori Staszewski, Marco Prinz, Jürgen Hench, Stephan Frank, Yvonne M.H. Versleijen‐Jonkers, Marije E. Weidema, Thomas Mentzel, Klaus Griewank, Enrique de Álava, Juan Díaz‐Martín, Miguel Á. Idoate, Kenneth Tou En Chang, Sharon Y. Y. Low, Adrián Cuevas-Bourdier, Michel Mittelbronn, Martin Mynarek, Stefan Rutkowski, Ulrich Schüller, Viktor Mautner, Jens Schittenhelm, Jonathan Serrano, Matija Snuderl, Reinhard Büttner, Thomas Klingebiel, Rolf Buslei, Manfred Gessler, Pieter Wesseling, Winand N.M. Dinjens, Sebastian Brandner, Zane Jaunmuktane, Iben Lyskjær, Peter Schirmacher, Albrecht Stenzinger, Benedikt Brors, Hanno Glimm, Christoph Heining, Òscar M. Tirado, Miguel Sáinz‐Jaspeado, Jaume Mora, Javier Alonso, Xavier García del Muro, Sebastián Morán, Manel Esteller, Jamal Benhamida, Marc Ladanyi, Eva Wardelmann, Cristina R. Antonescu, Adrienne M. Flanagan, Uta Dirksen, Peter Hohenberger ほか 11 名 - Nature Communications 2021 被引用: 547

  3. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA 2021 被引用: 325

  4. Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heribert Jürgens, Christof M. Kramm, André O. von Bueren, Frank Westermann, Matthias Fischer, Birgit Burkhardt, Wilhelm Wößmann, Michaela Nathrath, Stefan Bielack, Michael C. Frühwald, Simone Fulda, Thomas Klingebiel, Ewa Kościelniak, Matthias Schwab, Roman Tremmel, Pablo Hernáiz Driever, Johannes H. Schulte, Benedikt Brors, Andreas von Deimling, Peter Lichter, Angelika Eggert, David Capper, Stefan M. Pfister, David Jones, Olaf Witt - European Journal of Cancer 2016 被引用: 336

  5. A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

    著者: , , , , , , , , , , , - Frontiers in Immunology 2017 被引用: 110

  6. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012

    著者: , , , , , , , , , - Leukemia 2018 被引用: 268

  7. Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 358

  8. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georg F. Hoffmann, Ansgar Schulz, Fabian Hauck - Journal of Clinical Immunology 2023 被引用: 53

  9. Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uwe Kordes, Dieter Körholz, Ewa Kościelniak, Christof M. Kramm, Michaela Kuhlen, Andreas E. Kulozik, Britta Lamottke, Ivo Leuschner, Dietmar Lohmann, Andrea Meinhardt, Markus Metzler, Lüder Hinrich Meyer, Olga Moser, Michaela Nathrath, Charlotte M. Niemeyer, R. Nustede, Kristian W. Pajtler, Claudia Paret, Mareike Rasche, Dirk Reinhardt, Olaf Rieß, Alexandra Russo, Stefan Rutkowski, Brigitte Schlegelberger, Dominik T. Schneider, Reinhard Schneppenheim, Martin Schrappe, Christopher Schroeder, Dietrich von Schweinitz, Thorsten Simon, Monika Sparber‐Sauer, Claudia Spix, Martin Stanulla, Doris Steinemann, Brigitte Strahm, Petra Temming, Kathrin Thomay, André O. von Bueren, Peter Vorwerk, Olaf Witt, Marcin W. Włodarski, Willy Wössmann, Martin Zenker, Stefanie Zimmermann, Stefan M. Pfister, Christian P. Kratz - American Journal of Medical Genetics Part A 2017 被引用: 283

  10. Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 648

  11. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2008 被引用: 610

  12. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 438

  13. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Morland, Michael Paulussen, Andreas Ranft, Peter Reichardt, Hendrik Van den Berg, Keith Wheatley, Ian Judson, Ian Lewis, Alan Craft, Heribert Juergens, Odile Oberlin, on behalf of the Euro-E.W.I.N.G.99 and EWING-2008 Investigators - Journal of Clinical Oncology 2018 被引用: 166

  14. Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol

    著者: , , , , , , , , , , , , , , , , , , , , , - Frontiers in Oncology 2013 被引用: 139

  15. Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel

    著者: , , , , , , , , , , , , , , , - Frontiers in Immunology 2022 被引用: 50

  16. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation

    著者: , , , , , , , , , , , , , - Frontiers in Immunology 2019 被引用: 62

  17. More than mere games: a review of card and board games for medical education

    著者: , , , - Medical Teacher 2007 被引用: 195

  18. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers

    著者: , , , , , , , , , , , , - Bone Marrow Transplantation 2012 被引用: 173

  19. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2016 被引用: 121

  20. Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Selim Kuçi - Bone Marrow Transplantation 2018 被引用: 109

  21. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    著者: , , , , , , , , , , , , , , , , , , , , - Leukemia 2009 被引用: 521

  22. New insights to the MLL recombinome of acute leukemias

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Möricke, Martin Schrappe, Cristina N. Alonso, Beat W. Schäfer, J. Krauter, Dean A. Lee, Udo zur Stadt, Geertruy te Kronnie, Rosemary Sutton, Shai Izraeli, L. Trakhtenbrot, Luca Lo Nigro, Grigory Tsaur, Л. Г. Фечина, Tomasz Szczepański, Sabine Strehl, Denisa Ilenčíková, Mara Molkentin, Thomas Burmeister, Theo Dingermann, Thomas Klingebiel, Rolf Marschalek - Leukemia 2009 被引用: 411

  23. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

    著者: , , , , , , , , , , , - The Lancet Oncology 2005 被引用: 398

  24. The incidence and type of cancer in patients with ataxia‐telangiectasia via a retrospective single‐centre study

    著者: , , , , , , , , , , , - British Journal of Haematology 2021 被引用: 35